“…The most recognized prognostic factor in cervical cancer is the disease extension, usually estimated by the TNM/FIGO Corresponding author. E-mail address: kurnia@batan.go.id staging system (Tumor-Nodus-Metastasis / International Federation of Gynecology and Obstetrics) [4][5][6]. However, within each clinical disease stage, biological markers are needed to clarify the identification of high risk patients who may benefit from individualized therapeutic options of carcinoma cervix uterine [7].…”